glp-1 latest news Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford GLP-1 Overdoses Are Rising as
Description
It also has a longer half-life, meaning it stays active in the body for a longer period, which leads to more sustained appetite suppression and better blood sugar control
The phase 2a liver-specific trial showed: 1 mg dose: 42.9% reduction in liver fat 4 mg dose: 57.0% reduction in liver fat 8 mg dose: 81.4% reduction in liver fat 12 mg dose: 82.4% reduction in liver fat An 82% reduction in liver fat is extraordinary
One cohort study published in JAMA in November 2025 found that those who halted GLP-1 use before or early in their pregnancies gained more weight and had higher risks of pregnancy complications like hypertensive disorders, diabetes and preterm delivery compared to those who hadnt used the medications before
it does not apply to grandfathered plans or large group plans
10.1161/HYPERTENSIONAHA.112.195115 [DOI] [PubMed] [Google Scholar] 18
